Table 1.
Participant Characteristics by Ever/Never Incarceration Among Injection Drug Users (IDUs) Achieving Virologic Suppression (n = 437)
| Never incarcerated during follow-up (n = 255) | Incarcerated at least once during follow-up (n = 182) | |
| Male | 158 (62.0) | 142 (78.0) b |
| African-American | 241 (94.5) | 172 (94.5) |
| Age (median, IQR) | 45 (40–49) | 42 (38–46) b |
| Unemployed | 206 (81.4) | 142 (78.9) |
| Finished high school | 103 (40.7) | 65 (35.7) |
| Homeless | 38 (15.0) | 48 (26.7) b |
| CD4 count (cells/μL) b | ||
| ≥350 | 96 (42.7) | 63 (40.7) |
| 200–349 | 75 (33.3) | 51 (32.9) |
| <200 | 54 (24.0) | 41 (26.5) |
| HIV RNA level (copies/mL) b | ||
| ≤400 | 98 (43.2) | 44 (28.2) |
| 401–10 000 | 44 (19.4) | 44 (28.2) |
| >10 000 | 85 (37.4) | 68 (43.6) |
| Injection drug use during past 6 months b | ||
| None | 133 (52.4) | 49 (27.2) |
| Occasional | 68 (26.8) | 68 (37.8) |
| Daily | 53 (20.9) | 63 (35.0) a |
| Alcohol use during the past 6 months b | ||
| None | 136 (53.8) | 79 (44.9) |
| Occasional | 102 (40.3) | 68 (38.6) |
| Daily | 15 (5.9) | 29 (16.5) a |
| Receiving methadone maintenance | 59 (23.2) | 12 (6.6) a |
| Incarcerated during follow-up | ||
| Never incarcerated | 255 (100.0) | 0 (0.0) |
| Incarcerated once | 0 (0.0) | 65 (35.7) |
| Multiple incarcerations | 0 (0.0) | 117 (64.3) |
Data are reported as no. (%) unless otherwise indicated. Data obtained from first study visit after January 1, 1998, unless otherwise specified. Abbreviation: IQR, interquartile range.
a
Significant difference between groups (α = .05) using χ2 test.
b
Significant difference between groups (α = .05) using t test.